Lupin Recalls Morphine Sulfate Extended-Release Tablets Due to Impurity Failures
Lupin Pharmaceuticals is recalling 17,328 bottles of Morphine Sulfate Extended-Release Tablets because they failed impurity and degradation specifications.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The source explicitly identifies this as an FDA Class III recall, which the rubric defines as typically scoring 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Lupin Pharmaceuticals, Inc. is recalling 17,328 bottles of Morphine Sulfate Extended-Release Tablets, 15 mg. The product is manufactured by Novel Laboratories, Inc. and distributed under NDC 43386-540-01. The recall was initiated because the product failed impurities and degradation specifications.
The affected lots are S700220 (Exp. Apr 30 2019), S700604 (Exp. July 31 2019), and S800326 (Exp. Mar 31 2020). The product was shipped to five wholesalers and one supermarket chain, which may have further distributed the medication throughout the United States.
This is an FDA Class III recall, which indicates that the product is not likely to cause adverse health consequences. Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be returned to the pharmacy or distributor for disposal.
The recalled product
- Product
- MORPHINE SULFATE (MORPHINE SULFATE)
- Brand
- MORPHINE SULFATE
- Manufacturer
- LUPIN SOMERSET
- Category
- Drug — Prescription Opioid
- Hazard
- Affected units
- 17,328
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: S700220
- Exp. Apr 30 2019
- S700604
- Exp. July 31 2019
- S800326
- Exp. Mar 31 2020
UPCs (4)
- 0343386542017
- 0343386543014
- 0343386540013
- 0343386541010
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 5 recalled by LUPIN SOMERSET under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · MORPHINE SULFATE
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- ModerateMorphine sulfate oral solution recalled over a carton size mismatch
FDA (Drugs) · 2025-12-17
- HighMorphine Sulfate Tablets Recalled Over Failed Dissolution Specifications
FDA (Drugs) · 2025-03-12
- SevereMorphine Sulfate Injection Recalled Due to Defective Vials
FDA (Drugs) · 2021-10-06
- ModerateLupin Recalls Morphine Sulfate Tablets for Impurity Specification Failures
FDA (Drugs) · 2019-05-01
Same manufacturer · LUPIN SOMERSET
See all →- ModerateLupin Recalls Morphine Sulfate Extended-Release Tablets for Impurity Failures
FDA (Drugs) · 2019-05-01
- ModerateLupin Recalls Morphine Sulfate Extended-Release Tablets Due to Impurity Failures
FDA (Drugs) · 2019-05-01
- ModerateLupin Recalls Morphine Sulfate Extended-Release Tablets for Impurity Failures
FDA (Drugs) · 2019-05-01
- ModerateGavilyte-N Recalled for Incorrect Flavor Labeling on Orange and Cherry Packets
FDA (Drugs) · 2019-04-17
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities
FDA (Drugs) · 2019-01-30
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08